Telegraft retweeted
🌍 #FORUM30 united 102 experts from 36 countries to advance MPHO safety&traceability! Hosted by @ICCBBA, @CNTrapianti, @CentroSangue & supported by @WHO, we explored future therapies & global regulatory harmony. A pivotal step for patient care worldwide!
🔗iccbba.isbt128.org/forum30
Telegraft retweeted
📢now #online in the latest isse of @ISCTglobal @telegraft a recap of @ISBT128's a brief recap of #FORUM30 where I presented Current challenges in cell and gene therapy: a joint view from the European Committee of the @ISCTglobal and the @TheEBMT
🔗isctglobal.org/telegrafthub/…
Telegraft retweeted
📢Now online! Human pluripotent stem cell-derived #retinal #pigment #epithelial cells #underthemicroscope by Dr. Laura Baqué Vidal @karolinskainst in the latest issue of @telegraft, the newsletter of the @ISCTglobal
🔗isctglobal.org/telegrafthub/…
Telegraft retweeted
Advances in stem-cell #therapy could hold the key to treating age-related #macular degeneration (AMD), a leading cause of blindness. Learn how retinal pigment epithelial (RPE) cells are being developed to stop #vision loss & offer new hope for millions worldwide! #AMD @telegraft
Telegraft retweeted
Replying to @xinoxan @telegraft
🤔What?🧐RPE are specialized cells on the back of the eye playing a fundamental role in the homeostasis of the #retina, e.g. visual cycle recycling, phagocytosis of old photoreceptors, secretion of growth factors, transport of nutrients and water, capture of not-transduced light
Telegraft retweeted
🤔Why?🧐Age-related #macular #degeneration (AMD) is a prevalent progressive #blindness disease in the elderly worldwide caused by degeneration of #RPEs. Cell replacement therapies could help in the #treatment of AMD.
📚doi.org/10.22608/apo.2017251
Telegraft retweeted
🤔Who?🧐Current strategies for treating AMD involve stem-cell-based RPE products develop in both academua and industry.
🔗doi.org/10.1080/078538906009…
Telegraft retweeted
🤔When?🧐The interest on transplanting #RPE into #AMD patients started in the early 90's, when #fetal tissue material was used to transplant young and healthy RPEs that were able to slightly rescue some visual acuity in patients.
🔗doi.org/10.1007/bf00184273
Telegraft retweeted
🤔Where?🧐Leading countries developing clinical development of stem-cell-based RPE products include USA, Japan, Israel, UK, China and Republic of Korea. In some other countries, developments are still on the preclinical stage, including Sweden, Spain, India, Finland, Singapore.
Telegraft retweeted
🤔How?🧐#Stem cell-based #RPE products are #ATMP produced in compliance with pharmaceutical #GMP standards. Current #protocols yield >98% pure RPEs, although some developers use cell sorting procedures to enrich #RPEs from other #impurities.
Telegraft retweeted
💡If you want to learn more on #pluripotent #stem cell-derived #epithelial #retinal #pigmental #cells, please read Dr. Laura Baqué Vidal's article in the latest issue of @Telegraft following this link:
isctglobal.org/telegrafthub/…
Telegraft retweeted
In this #UTM @telegraft article, @CaicedoLab & @sebastianjpc1 present #mitochondria as a cell-free therapeutic option.
🔗isctglobal.org/telegrafthub/…
Telegraft retweeted
🤔Why?🧐The simplicity of AMT/T contrasts with complexity of studying its potential #therapeutic effect based on the principle that damaged cells and tissues require #mitochondria to support phenotypic recovery via nanotubular structures and microvesicles.
pubmed.ncbi.nlm.nih.gov/3366…
Telegraft retweeted
🤔What? 🧐#Mitochondria enabled #evolution& #diversification of complex life forms, driving energy production and support cellular #signaling, #survival& #cellularcommunication, leading to development of artificial mitochondrial transfer/transplant (AMT/T)
pubmed.ncbi.nlm.nih.gov/3710…
Telegraft retweeted
📢 #mitochondria as a #therapeutic option this month in the latest issue of @ISCTglobal @telegraft by Drs. Caicedo lab from @USFQ_Ecuador
🔗 isctglobal.org/telegrafthub/…
Telegraft retweeted
🤔How?🧐#Challenges exist in the GMP #scaleup #manufacturing of mitochondria from healthy tissues in accordance to #pharmaceutical #regulations. Advances in production of other AdvancedTherapies might help in the sourcing of viable & functonal mitochondria
pubmed.ncbi.nlm.nih.gov/3290…
Telegraft retweeted
🤔Who?🧐There's no #commercial mitochondria preparations as #LivingDrug yet. However, the evidence that cells uptake #mitochondria from their surroundings or from other cells has spurred #interest in both in #academia and #industry.
pubmed.ncbi.nlm.nih.gov/3801…
Telegraft retweeted
I am thrilled to have my video interview for the @ISCTglobal @telegraft Member Spotlight with Dr. Erja Kerkelä, Ph.D. out now! Enjoy this wonderful conversation with a fantastic researcher and champion of team science! youtu.be/k8XHLjlK_PY?si=tIS1… via @YouTube
Telegraft retweeted
My latest editorial on CAR-MSCs for the @ISCTglobal @telegraft - had a lot of fun writing this one! Check out the inspiration article from @kenderian_ss linked within. Enjoy! #celltherapy
Ever heard of CAR-MSCs? In the latest edition of the Telegraft, Editor @AshleyAKrull introduces – or re-introduces - the concept of CAR-MSCs and how the latest version of these cells from the lab of @kenderian_ss could impact the field.
Read Now: buff.ly/3vSeg6Q









